Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,463 total articles

Beam Global Signs Definitive Agreement to Acquire Drone Technology Company ScoutDI, Creating a Vertically Integrated U.S. Drone Platform for Industrial and Defense Markets

Beam Global Signs Definitive Agreement to Acquire Drone Technology Company ScoutDI, Creating a Vertically Integrated U.S. Drone Platform for Industrial and Defense Markets

Beam Global has signed a definitive agreement to acquire Norway-based drone technology company ScoutDI for approximately $24 million. The acquisition aims to establish Beam as a vertically integrated U.S. drone manufacturer with capabilities in energy, mobility, and defense markets. ScoutDI's drone systems, including those with conditional U.S. Dep…

Atlantic HPC Group Inc Appoints Leo Lin as Chief Executive Officer

Atlantic HPC Group Inc Appoints Leo Lin as Chief Executive Officer

Atlantic HPC Group Inc, a U.S.-based digital infrastructure company focused on bitcoin mining, announced the appointment of Leo Lin as its new CEO effective October 1, 2026. Lin brings over 20 years of executive experience, including leadership roles in tech and finance sectors. The company is planning to expand its operations from bitcoin mining t…

Crane NXT Appoints Jeong H. Kim to Board of Directors

Crane NXT Appoints Jeong H. Kim to Board of Directors

Crane NXT, a global leader in authentication and traceability technologies, announced the appointment of Jeong H. Kim to its Board of Directors effective October 29, 2026. Dr. Kim brings extensive leadership experience in advanced technologies and commercializing innovations, expected to support Crane NXT's growth and market leadership.

Sportradar Announces Agreement for the Divestiture of Coaching and Scouting Business of Synergy Sports to Teamworks Innovations

Sportradar Announces Agreement for the Divestiture of Coaching and Scouting Business of Synergy Sports to Teamworks Innovations

Sportradar Group AG announced an agreement to sell Atrium Sports, the coaching and scouting segment of Synergy Sports, to Teamworks Innovations for $170 million in cash. This divestiture allows Sportradar to streamline its business and concentrate on its principal betting, gaming, and media operations while retaining key technology assets. The tran…

BrewDog Rallies Beer Lovers Across the UK to Choose Craft

BrewDog Rallies Beer Lovers Across the UK to Choose Craft

BrewDog, owned by Tilray Brands, is spearheading a UK-wide campaign called 'Choose Craft' to revitalize the craft beer market. The campaign celebrates quality ingredients, flavor, and the craft beer community, driving a 2.87x sales increase in key products. BrewDog also secured eight new on-trade partnerships, expanding its footprint in entertainme…

Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes

Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes

Caspian Therapeutics, formed from menin-inhibitor research at Kura Oncology, is advancing KO-7246, a novel oral menin inhibitor aimed at treating diabetes by restoring beta-cell function. Kura Oncology and Caspian will present preclinical data at an upcoming investor webcast, highlighting progress and potential applications of this therapy in cardi…

Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026

Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026

Zenas BioPharma announces presentations of clinical data for Orelabrutinib and Obexelimab across multiple sclerosis subtypes at MSToronto2026 conference, highlighting progress in late-stage trials and potential new therapies for progressive MS with unmet needs.

OrthoPediatrics Expands Its Lower Extremity Bracing Portfolio with the Launch of OPSB® Knee 'TractorFIX

OrthoPediatrics Expands Its Lower Extremity Bracing Portfolio with the Launch of OPSB® Knee 'TractorFIX

OrthoPediatrics Corp. announced the launch of the OPSB® Knee 'TractorFIX, a pioneering pediatric bracing solution designed to manage knee contractures in young patients undergoing tibial treatment with external fixators. This new product expands their specialty bracing portfolio, offering a standardized alternative to custom-built solutions and int…

Marex announces changes to Group Board

Marex announces changes to Group Board

Marex Group Limited announced that Robert Pickering has stepped down as Chair of the Board after overseeing significant growth, including the company's IPO on Nasdaq in April 2024. John Pietrowicz, former CFO of CME Group and current Board member, has succeeded him as Chair, bringing valuable expertise in financial markets and mergers and acquisiti…

OR Royalties Announces Preliminary Q3 2026 GEO Deliveries

OR Royalties Announces Preliminary Q3 2026 GEO Deliveries

OR Royalties Inc. announced its preliminary third quarter 2026 results, earning 20,237 gold equivalent ounces and generating revenues of $90.2 million with a high cash margin of 96.8%. The company also completed a $15 million royalty acquisition during the quarter and maintains a strong cash position of $76.7 million. The revolving credit facility …

Cadrenal Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process to Maximize Value of its Orphan Thrombo-Inflammatory Therapeutics

Cadrenal Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process to Maximize Value of its Orphan Thrombo-Inflammatory Therapeutics

Cadrenal Therapeutics has engaged Tungsten Advisors to lead a formal strategic process aimed at exploring various transactions to maximize the value of its orphan thrombo-inflammatory therapeutics portfolio. The company’s pipeline has reached significant clinical and regulatory milestones, including FDA alignment on a Phase 3 pathway for lead candi…

VERAXA Biotech Provides Overview on Implementation of  FDA-Aligned Human-Relevant Models into R&D Strategy

VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy

VERAXA Biotech AG updates on implementing New Approach Methodologies (NAMs) aligned with FDA guidelines into its R&D, enabling faster clinical progression and significantly decreasing animal testing. Utilizing advanced human-relevant models such as 3D spheroids and patient-derived xenografts, VERAXA demonstrates improved preclinical predictivity an…

BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds

BillionToOne’s Tissue-Free Northstar Response® Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds

BillionToOne announced the publication of a real-world peer-reviewed study demonstrating that its tissue-free Northstar Response liquid biopsy assay tracks cancer treatment response as effectively or better than a commercially available tumor-informed assay, without needing tumor tissue sequencing. The study showed high concordance in measuring tum…

Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease

Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease

Arvinas, Inc. announced final data from its Phase 1 clinical trial of ARV-102, a PROTAC degrader targeting LRRK2, in Parkinson’s disease patients. The trial demonstrated that ARV-102 crosses the blood-brain barrier, reduces LRRK2 protein levels in cerebrospinal fluid, and leads to improvements in oculomotor function and biomarkers related to neurod…

Alpha Compute’s GAMEE Reports Q3 Record 94% YoY Growth, Reaches Monthly Profitability with over 118 million game-plays, Expands Into AI-Powered Consumer Applications

Alpha Compute’s GAMEE Reports Q3 Record 94% YoY Growth, Reaches Monthly Profitability with over 118 million game-plays, Expands Into AI-Powered Consumer Applications

Alpha Compute Corp.'s subsidiary GAMEE reported a record 94% year-over-year revenue growth in Q3 2026, reaching $1.71 million and achieving monthly profitability for the first time. The company has expanded into AI-powered consumer applications, leveraging its gaming expertise and AI capabilities, with initial AI product launches expected in Q4 202…

Eagle Bancorp Announces Earnings Call on October 22, 2026

Eagle Bancorp Announces Earnings Call on October 22, 2026

Eagle Bancorp, Inc., a leading community bank holding company based in Bethesda, Maryland, announced that it will hold a teleconference on October 22, 2026 to discuss its third-quarter financial results. The earnings will be released post-market on October 21, 2026. The event includes participation via webcast and is aimed at the financial communit…